Published in Drug Law Weekly, April 11th, 2006
Primary among the Academy's objections is the fact that many of the stipulations outlined in the CMS Draft Guidance are counter to "best practices" normally followed in the private sector. The Academy believes closer adherence to recognized best practices would enhance pharmacy coverage for beneficiaries and achieve greater cost efficiencies for both plan sponsors and CMS. Of key concern is CMS' stipulation that "all or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.